martes, 23 de enero de 2018

ACIP | Home | Advisory Committee on Immunization Practices | CDC

ACIP | Home | Advisory Committee on Immunization Practices | CDC

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People

Register for upcoming February ACIP meeting

February 21-22, 2018
laptop

Deadline for registration:
Non-US Citizens: January 24, 2018
US Citizens: February 5, 2018
Registration is NOT required to watch the live meeting webcast or to listen via telephone.

On November 9, 2017, FDA approved a new hepatitis B vaccine, HEPLISAV-B, for use in adults 18 years of age and older.  HEPLISAV-B is the first licensed vaccine using a CpG adjuvant* and is administered as two doses given one month apart.  Further details on this vaccine’s approval can be found at Vaccines Licensed for Use in the United States.
*Cytosine phosphoguanine (CpG) 1018 adjuvant

No hay comentarios: